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The aerobic metabolism of fluorobenzene by Rhizobiales sp. strain F11 was investigated. Liquid chromatog-
raphy-mass spectrometry analysis showed that 4-fluorocatechol and catechol were formed as intermediates
during fluorobenzene degradation by cell suspensions. Both these compounds, unlike 3-fluorocatechol, sup-
ported growth and oxygen uptake. Cells grown on fluorobenzene contained enzymes for the ortho pathway but
not for meta ring cleavage of catechols. The results suggest that fluorobenzene is predominantly degraded via
4-fluorocatechol with subsequent ortho cleavage and also partially via catechol.
During the last decades, environmental contamination by
fluorinated organic compounds has received increasing atten-
tion because of their use as herbicides, fungicides, surfactants,
refrigerants, intermediates in organic synthesis, solvents, and
pharmaceuticals (11). Whereas the biodegradation of chlori-
nated compounds has been studied quite extensively (19), little
is known about the bacterial metabolism of fluoroaromatic
compounds, even though there have been several reports on
the degradation of fluorobenzoic acids (5, 6, 7, 16). With chlo-
roaromatics, most degradation routes involve dioxygenase- and
dehydrogenase-mediated conversion to the corresponding
chlorocatechols, which are further metabolized by a dioxygen-
ase that cleaves the aromatic ring. Dehalogenation occurs dur-
ing metabolism of the ring-cleavage products (19). Most de-
scribed strains degrade chlorocatechols via the ortho-cleavage
pathway (14, 18, 19, 20), but meta cleavage of 3-chlorocatechol
can also occur (13), even though the meta-cleavage route is
often unproductive due to the formation of toxic or dead-end
products (1, 19). Dehalogenation may in some cases occur
prior to ring cleavage. For example, mutants of Pseudomonas
sp. strain B13 and Alcaligenes eutrophus B9 that grow on 2-flu-
orobenzoate use a dioxygenase to convert it to catechol, with
concomitant decarboxylation and defluorination (5). Pseudo-
monas putida strain CLB 250, which can use three different
2-halobenzoates, also converts these substrates by initial dehalo-
genating dioxygenation (6), and a defluorinating 4-fluorobenzo-
ate monooxygenase has been reported as well (16).
The present paper describes a metabolic pathway for fluoro-
benzene (FB). Information about the bacterial metabolism of
this compound is scarce, despite studies on its chlorinated
analogue (13, 18). Lynch et al. (12) described the oxidation of
FB to 3-fluorocatechol by a strain of Pseudomonas putida, but
in this study FB was not used as a carbon source. Recently, FB
was reported to be completely degraded by a bacterial consor-
tium (2) and by a pure bacterial culture that utilized it as a sole
carbon and energy source (3). This gram-negative bacterium,
phylogenetically classified within the order Rhizobiales, was
named strain F11 and was used here to investigate the metab-
olism of FB.
Intermediates produced during FB degradation. In order to
obtain information about the degradation pathway of FB, we
tested which intermediates accumulated upon incubation of
concentrated cell suspensions of strain F11 with FB. First, cells
were grown in sealed flasks on FB in mineral medium as
described previously (3), harvested by centrifugation (10,000 
g for 15 min at 4°C), washed twice with mineral medium, and
resuspended in the same medium to give an optical density at
600 nm of 0.3. Glucose (1 mM) was added, since it was found
in preliminary experiments that this enhanced degradation of
FB and stimulated accumulation of intermediates. The suspen-
sions were incubated in closed flasks with FB, and samples
were taken at appropriate times, centrifuged, and subjected to
high-performance liquid chromatography (HPLC), gas chro-
matography, and fluoride measurements. Fluoride was mea-
sured with a Dionex Dx-120 ion chromatograph equipped with
an Allsep A-2 anion column from Alltech, and the eluent was
a mixture of NaHCO3 and Na2CO3 in deionized water. For FB
analysis, culture samples were extracted with diethylether
and analyzed by gas chromatography as described previously
(3). It was observed that whole cells of strain F11 completely
removed 1.1 mM FB in 13 h, but stoichiometric fluoride
release was seen only after 29 h (Fig. 1). This indicates that
fluorinated intermediates did temporarily accumulate but
that there was no formation of high levels of fluorinated
dead-end metabolites.
Samples (20 l) from the same culture fluid were also ana-
lyzed by HPLC and liquid chromatography-mass spectrometry
(LC-MS). HPLC analysis was carried out on a Lichrospher 100
RP8 reversed-phase column in connection with Jasco PU-980
pumps, a Jasco MD-910 diode array detector, and a Jasco
UV-2075 detector. Compounds were isocratically eluted at a
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flow rate of 1 ml/min with a solution of water-acetonitrile
(80:20) and 10 mM formic acid. LC-MS was carried out with
a Micromass ZMD detector equipped with a XTerra MS, a
SymmetryShield C8 column (4.6 mm by 150 mm), a 996 pho-
todiode array detector, and a 2690 separations module, all
from Waters. While degradation proceeded, five metabolites
(compounds I to V) appeared in the culture medium (Table 1).
Four of these (compounds I, II, IV, and V) were completely
consumed during prolonged incubation. One minor metabolite
(compound III) remained in the culture supernatant even after
incubation for 48 h.
Metabolite I, which appeared early, coeluted with catechol
and had a molecular mass (negative-mode MS) of m/z  109
(M-H). Metabolite II was identified as 4-fluorocatechol on
the basis of cochromatography with a standard in HPLC anal-
ysis and its negative-mode mass spectrum with m/z  126.91
(M-H). The dead-end metabolite III was identified as cis-
dienelactone by cochromatography and mass spectrometry
(positive ionization, m/z  140.04 [MH]). Metabolites IV
and V could not be identified, since no ionization was obtained
with LC-MS.
The occurrence of the two catechols during the initial 20 h of
FB degradation (Fig. 1) suggests that strain F11 converts FB
partially to catechol and partially to 4-fluorocatechol during
the first metabolic step. Approximately 0.6 mM of the FB that
was converted transiently appeared as 4-fluorocatechol, and
about 0.3 mM was detected as catechol. This is in agreement
with the observation that significant fluoride release is taking
place already during the initial period of FB degradation, i.e.,
when catechol is formed but that fluoride release is only com-
plete when the intermediate 4-fluorocatechol and possibly
other fluorinated metabolites have been degraded. The forma-
tion of both catechol and 4-fluorocatechol from FB is also
consistent with the ability of strain F11 to grow on both of
these catechols. The fact that catechol remained in the me-
dium for quite a long time even though it is a better growth
substrate than 4-fluorocatechol suggests inhibition of the cat-
echol pathway by the presence of 4-fluorocatechol.
Substrate-dependent oxygen consumption by whole cells. In
order to test the inducibility of FB transformation activity,
oxygen uptake measurements were done. Cells of strain F11
were grown on FB, benzene, or citrate, harvested by centrifu-
gation, washed, resuspended to a density of 0.43 mg of cellular
protein per ml, and transferred to a stirred vessel that was
equipped with a fiber optic oxygen sensor (MOPS-1; ProSense
BV, Hanover, Germany). The rate of O2 consumption was
measured at room temperature in the presence of different
substrates (Table 2).
Cells grown on FB oxidized fluorobenzene and cis-1,2-dihy-
drobenzenediol as well as 4-fluorocatechol and were also
highly induced for the oxidation of catechol. Rapid oxidation
of catechol, 4-fluorocatechol, and cis-1,2-dihydrobenzenediol
was also obtained with cells that were pregrown on benzene.
With fluorobenzene and benzene, these cells showed even
higher oxygen uptake rates than cells grown on FB. With cells
grown on citrate, the aromatic substrates were not oxidized,
suggesting that the formation of the first catabolic enzyme was
induced during growth on the aromatic substrates and re-
pressed on citrate. The oxygen uptake rates with 3-fluorocat-
echol were very low, independent of whether the cells were
grown on FB, benzene, or citrate. The patterns of oxygen
FIG. 1. Accumulation of metabolites during degradation of 1.1
mM FB by strain F11. Symbols:■, FB (calculated as if all substrate was
present in the liquid phase); Œ, fluoride; X, 4-fluorocatechol; F, cat-
echol; }, optical density at 600 nm. Liquid phase FB is in equilibrium
with gas-phase substrate according to the Henry coefficient (H  Cg/Cl
 0.258). The closed flasks had a volume of 1,200 ml and contained
250 ml medium.
TABLE 1. HPLC retention times and absorption maxima of
metabolic intermediates formed by F11 cells exposed to
fluorobenzene in the presence of glucose
Compound Retentiontime (min) max (nm)
Growth in
substrate a
Catechol (metabolite I) 8.4 195, 276 
4-Fluorocatechol (metabolite II) 13 190, 280 
cis-Dienelactone (metabolite III) 8 190, 220, 275 NT
Metabolite IV 23.4 273 NT
Metabolite V 6 210 NT
Fluorobenzene 65 260 
3-Fluorocatechol 10.5 190, 267 
cis,cis-Muconic acid 6.25 260 
Phenol 15 270 
4-Fluorophenol 22 190, 277 
Hydroquinone 5.2 280 NT
1,2,4-Benzenetriol 4 280 NT
a Abbreviations: NT, not tested; , no growth after 14 days; , clearly visible
growth in liquid culture after 4 days.
TABLE 2. Substrates oxidized by fluorobenzene-, benzene-, and
citrate-grown cells of strain F11a
Assay substrate
Rate of oxygen consumption (nmol/min
per mg of cells) after growth with:
Fluorobenzene Benzene Citrate
Fluorobenzene 66 420 0.1
Benzene 2 220 0.1
cis-1,2-Dihydrobenzenediol 160 400 0.1
Catechol 570 340 0.1
3-Fluorocatechol 0.1 0.1 0.1
4-Fluorocatechol 300 570 0.1
Citrate 0.1 0.1 151
a Oxygen consumption was measured with an oxygen sensor as described in
Materials and Methods. All substrates were used at a concentration of 1 mM.
Results represent the means of the results of at least three independently per-
formed experiments. Oxygen uptake experiment results are corrected for endog-
enous respiration; replicates showed less than 10% variation.
consumption show that oxidation of catechol, 4-fluorocatechol,
and cis-1,2-dihydrobenzenediol was induced by FB and ben-
zene, whereas 3-fluorocatechol was never oxidized. When
batch cultures of strain F11 growing with 1 mM of FB were
supplemented with 0.1 mM of 3-fluorocatechol, FB was no
longer converted by the cells, and fluoride, measured with a
fluoride-selective electrode (2), was not released.
Enzymes involved in the degradation of FB. To investigate
whether degradation of FB proceeds via meta or ortho cleav-
age, the presence of several enzymes involved in these routes
was tested (Table 3). Late exponential FB-grown cells were
harvested by centrifugation, washed twice with 0.1 M Tris-HCl
buffer (pH 7.5) containing 0.1 mM 1,4-dithiothreitol, and dis-
rupted by sonication in the same buffer. After centrifugation
(90,000  g for 60 min at 4°C) the clear supernatant was used
as the cell extract for enzyme assays. Its protein content was
determined with Coomassie brilliant blue using bovine serum
albumin as the standard.
Catechol 2,3-dioxygenase was measured by determining the
formation of 2-hydroxymuconic semialdehyde (ε  44,000
M1 cm1) at 375 nm, according to the method of Nozaki (15).
(Fluoro) catechol 1,2-dioxygenase activity was measured simi-
larly, as described by Dorn and Knackmuss (4) (εcis,cis-muconate
 16,800 M1, ε2-fluoro-cis,cis-muconate  14,900 M
1 cm1, ε3-
fluoro-cis,cis-muconate  14,900 M1 cm1). Muconate cycloi-
somerase activity was measured by following the consumption
of cis,cis-muconate in an assay mixture containing 30 mM
Tris-HCl (pH 8.0), 1 mM MnCl2, and 0.1 mM cis,cis-muconate.
Dienelactone hydrolase activity was determined by following at
280 nm (ε  17,000 M1 cm1) the decrease in the level of 0.1
mM cis-dienelactone that was incubated with enzyme in 10
mM histidine-HCl (pH 6.5). Maleylacetate was prepared on
the day of its use by alkaline hydrolysis of cis-dienelactone (8),
and the reductase was measured by following maleylacetate
(0.1 mM)-dependent NADH (0.2 mM) oxidation at 340 nm in
50 mM Tris-HCl (pH 7.5). Activities were corrected for sub-
strate-independent NADH oxidation. 3-Oxoadipate:succinyl-
coenzyme A transferase was measured as described by Mars et
al. (13). One unity of activity was defined as the amount of
enzyme required to convert 1 mol of substrate per min at
25°C.
Activities of the ortho pathway enzymes catechol 1,2-dioxy-
genase, muconate cycloisomerase, maleylacetate reductase,
and 3-oxoadipate:succinyl-coenzyme A transferase were found
in cell extracts of strain F11 grown on FB. Catechol 2,3-dioxy-
genase activity was not detected, indicating that strain F11
does not use a meta-cleavage pathway to degrade FB. A 1,2-
dioxygenase activity was detected with both catechol and
4-fluorocatechol but was hardly detected with 3-fluorocatechol.
Instead, the catechol 1,2-dioxygenase activity was reduced by
70% and 90% in the presence of 0.1 and 0.5 mM 3-fluorocat-
echol, respectively. A muconate cycloisomerase activity with
respect to cis,cis-muconic acid was also detected. No activity
was found for cis-dienelactone hydrolase in extracts of strain
F11. These observed enzyme activities suggest that the cat-
echols in the FB degradation pathway undergo ortho cleavage.
We judge it highly unlikely that 3-fluorocatechol is an inter-
mediate in FB degradation pathway, since it was not used as a
growth substrate and it strongly inhibited FB degradation and
growth and since no dioxygenase activity with 3-fluorocatechol
was detected in cell extracts of strain F11 grown on FB. This
conclusion is in line with the previously described resistance of
the expected product 2-fluoro-cis,cis-muconic acid to enzy-
matic cycloisomerization (23), although it is risky to generalize
such a finding to other organisms. Furthermore, in mutants of
Alcaligenes eutrophus B9 and Pseudomonas sp. strain B13 that
use 2-fluorobenzoate for growth, the formation of toxic 3-fluo-
rocatechol is prevented by loss of dihydrodihydroxybenzoate
dehydrogenase activity, allowing growth on catechol that can
be formed by initial dioxygenation of the aromatic ring (5). The
absence of a 3-halocatechol intermediate clearly distinguishes
the fluorobenzene pathway of strain F11 from chlorobenzene
catabolic pathways, which proceed via 3-chlorocatechol (13, 17,
18). This could explain the lack of growth of strain F11 on
chlorobenzene.
Pathway of FB degradation. We propose the pathway for FB
metabolism shown in Fig. 2. The initial attack of FB by dioxy-
genase activity yields two different fluorinated dihydrodiols.
The 4-fluoro-cis-benzene-1,2-dihydrodiol that is produced is
transformed into 4-fluorocatechol by a dihydrodiol dehydroge-
nase. Conversion of the other product, 1-fluoro-cis-benzene-
1,2-dihydrodiol, to catechol can proceed without involvement
of dehydrogenase that reduces a cofactor, since the electrons
are transferred to the fluoride that is being released (Fig. 2).
Simultaneous conversion of a fluorinated compound to cate-
chol and a fluorinated catechol was described earlier for the
degradation of 2-fluorobenzoate by Pseudomonas sp. strain
B13 and strain FLB300 (5, 7).
The capability of strain F11 cells to use 4-fluorocatechol as
a growth substrate, its transient accumulation in cell suspen-
sions to higher levels than catechol, and the fact that 4-fluo-
rocatechol stimulated oxygen uptake by whole cells lead to the
conclusion that 4-fluorocatechol is the predominant interme-
diate. The occurrence of 4-fluorocatechol as an intermediate
has also been described for the aforementioned -proteobac-
terium strain FLB300, which degrades both benzoate and
all monofluorosubstituted benzoates (7). The metabolism of
4-fluorocatechol is proposed to proceed through ortho cleav-
age by a (fluoro)catechol 1,2-dioxygenase that yields 3-fluoro-
cis,cis-muconate. This product could be transformed with
concomitant defluorination into maleylacetate via either 4-flu-
oromuconolactone or another lactone derivative. ortho cleav-




(U • mg of
protein1)
Catechol 1,2-dioxygenase Catechol 0.96
3-Fluorocatechola 0.009
4-Fluorocatechol 0.16
Catechol 2,3-dioxygenase Catechol 0.002
Muconate cycloisomerase cis,cis-Muconic acid 0.200
Dienelactone hydrolase cis-Dienelactone 0.002




a Activity with 3-fluorocatechol was tested both at 0.5 and 0.1 mM; the results
obtained were always very similar.
b Numbers represent the means of the results of at least three independently
performed experiments.
age of 4-fluorocatechol is also a key step in the metabolism of
3- and 4-fluorobenzoate by several bacterial strains (9, 21, 22,
24). These convert 4-fluorocatechol via 3-fluoro-cis,cis-mu-
conate and 4-fluoromuconolactone (22, 24) or via a non-fluor-
inated dienelactone intermediate (24). If 4-fluorocatechol me-
tabolism in strain F11 proceeds in the same way, this could also
explain the accumulation of cis-dienelactone since it can slowly
be formed as a side product during spontaneous or enzyme-
catalyzed dehydrodefluorination of 4-fluoromuconolactone
(23, 24). This pathway would also allow formation of proto-
anemonin.
Maleylacetate can be channeled into the tricarboxylic acid
cycle via 3-oxoadipate. Catechol, the minor product of the
initial dioxygenation reaction, is proposed to be metabolized to
cis,cis-muconate, converted to the lactone derivative, and then
also channeled into the 3-oxoadipate route (Fig. 2).
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